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Abstract
The aim of this study was to compare the effects of purified exopolysaccharides
from Lactobacillus rhamnosus RW-9595M with those of a well-known prebiotic
(short-chain fructo-oligosaccharides) on infant colonic microbiota using a new
three-stage chemostat model with immobilized infant faecal microbiota. Two
continuous cultures with different faecal inocula were tested with different
compositions of carbohydrate media. During the first fermentation (F1), fructo-
oligosaccharides tested at a concentration of 9.8 g L1 increased the number of
lactobacilli and decreased coliforms both in gel beads and in effluent from all three
reactors, in agreement with data from the literature. During the second fermenta-
tion (F2), the effect of fructo-oligosaccharides tested at a lower concentration
(7.5 g L1) was reduced compared with F1. Fructo-oligosaccharides also increased
total organic acid concentration and decreased ammonia production. Results
obtained for exopolysaccharide tested at 1.5 g L1 indicate that exopolysaccharides
from L. rhamnosus RW-9595M was not metabolized by infant microbiota and
lacked any prebiotic effect.
Introduction
The colonic microbiota is a complex ecosystem having great
effects on human health. Such complexity involves host
requirements for bacterial fermentation products, coloniza-
tion resistance to microbial pathogens, activation or de-
struction of genotoxins and mutagens, and modulation of
immune system functions (Macfarlane & McBain, 1999).
Throughout life, a succession of bacterial equilibria occurs
in the intestinal human microbiota. It is during infancy,
however, that the bacterial composition and activity of the
intestinal ecosystem are established, factors that contribute
greatly to the foundation of health. Indeed, it has been
suggested that interactions between intestinal microbes and
host not only have short-term effects on immune functions
and early development but could also exert long-term effects
on health, disease and mortality risks in adulthood (Reid,
2004).
In infancy, the microbial ecology of the gut is strongly
influenced by diet. It is generally believed that breast-fed
infants have a microbiota dominated by bifidobacteria and
lactobacilli, creating a protective environment against
pathogens. Formula-fed infants, having a more complex
microbiota, are more susceptible to intestinal disorders
(Mountzouris et al., 2002). Human milk contains a high
amount of oligosaccharides, which stimulate the growth of
indigenous bifidobacteria and lactobacilli and may contri-
bute to the protection of breast-fed infants against infections
and inflammations (Kunz & Rudloff, 1993).
Attempts have been made to modulate the microbial
balance of colonic microbiota with the aim of improving
the health and well-being of formula-fed infants. This can be
achieved either by oral administration of live microorgan-
isms known as probiotics, or by consumption of nondiges-
tible food ingredients that selectively stimulate the growth
and/or activity of beneficial bacteria (Bakker-Zierikzee et al.,
2005). The main bacterial populations targeted by these
food ingredients, also called prebiotics, are bifidobacteria
and lactobacilli, which are known to have health-promoting
properties such as inhibition of exogenous pathogens.
The most effective prebiotics in infant diet are oligosac-
charides such as fructo-oligosaccharides (FOS) and galacto-
oligosaccharides (GOS) (Ghisolfi, 2003). The most studied
prebiotics, FOS, escape the upper gastrointestinal (GI)
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digestion, and once in the colon exert a bifidogenic effect
causing decreases in Bacteroides spp. and clostridia counts.
FOS also promote an increase in short-chain fatty acids
(SCFA) concentration, particularly of butyrate (Gibson
et al., 1995; Rastall & Gibson, 2002). It has been suggested
that other food compounds such as exopolysaccharides
(EPS) from lactic acid bacteria exert prebiotic effects on
human intestinal microbiota (Dal Bello et al., 2001),
although only data from in vitro tests have been published.
EPS are produced by numerous bacteria in association with
their cell surface or are excreted in the fermentation med-
ium. They are believed to be implicated in bacterial protec-
tion (Roberts, 1996), and are widely used in the food
industry to improve food texture because of their rheologi-
cal properties (De Vuyst & Degeest, 1999). In the past
decade, the interest in EPS produced by lactic acid bacteria
has grown because of their GRAS (generally regarded as
safe) status (Sutherland, 1998) and their putative health-
promoting effects (Ruas-Madiedo et al., 2002).
In this study, we tested the effects of an EPS from
L. rhamnosus RW-9595M and FOS on infant microbial
ecology using a new three-stage continuous fermentation
colonic model with immobilized faecal microbiota (Cinquin
et al., 2004, 2006). Composition and activity of infant
microbiota as affected by carbohydrate composition were
monitored during two continuous culture experiments
carried out over 33 and 34 days. The effects of EPS and
FOS were also specifically tested on four bifidobacterial
species commonly encountered in infant faeces using a set
of bifidobacterial species-specific 16S rRNA-targeted oligo-
nucleotide probes and fluorescence in situ hybridization
(FISH).
Materials and methods
Bacterial strains
Lactobacillus rhamnosus RW-9595M, a high EPS-producer
strain, was obtained from the Lactic Acid Bacteria Research
Network (RBL Network) culture collection (Dairy Research
Centre STELA, Universite´ Laval, Que´bec, QC). This culture
was isolated from L. rhamnosus ATCC 9595M and shown to
be a stable EPS mutant (Dupont et al., 2000). EPS from
L. rhamnosus RW-9595M are large polymers with high
molecular weight (5 107Da) and a repeated unit com-
posed of pyruvate, 1; D-glucose, 2; D-galactose, 1; and
L-rhamnose, 4 (Van Calsteren et al., 2002).
Bacterial strains used for probe validation and listed in
Table 1 were obtained from the Deutsche Sammlung von
Milkoorganismen und Zellkulturen (DSMZ, Braunschweig,
Germany). They were cultivated in de Man Rogosa and
Sharp (MRS) broth supplemented with cysteine (0.05%)
under anaerobic conditions (CO2 :N2) at 37 1C.
EPS production and purification
EPS production and quantification were carried out as
described by Bergmaier et al. (2001). Briefly, the strain was
subcultured twice in MRS broth medium before being
inoculated at 10% (volume in volume, v/v) in basal mini-
mum medium (BMM) (Morishita et al., 1981) supplemen-
ted with glucose (40 g L1) and tryptone (2 g L1) in a 15 L
working-volume bioreactor (Inox-tech Inc., Montreal, QC).
Fermentation was carried out aerobically at 37 1C and
controlled at pH 6 by the addition of 6N NH4OH for 48 h.
The fermented medium was then heated at 100 1C for
15min in order to inactivate bacteria and to denature EPS-
degrading enzymes, cooled and centrifuged (25min,
13 200 g) to remove bacteria. The supernatant (15 L) was
ultrafiltrated and diafiltrated with four volumes of water
using a 50 kDa molecular weight cut-off membrane (Romi-
con, Worburn, MA) to reach a final volume of 2 L, and then
freeze-dried. Two EPS powders were prepared, one for F1
and one for F2. EPS in the powder was quantified with a
phenol-sulphuric test (Dubois et al., 1956), residual low-
molecular-weight carbohydrates were tested in the final
filtrate and reported to powder composition, and protein
content was evaluated with the Lowry test.
Faecal sample collection, preparation and
immobilization
Faecal samples used for immobilization were collected from
two healthy 6-month-old infants and prepared for immobi-
lization as previously described (Cinquin et al., 2006). The
immobilization procedure was based on a dispersion pro-
cess in a two-phase system, as described (Cinquin et al.,
2004). The autoclaved polymer solution [gellan gum 2.5%
(weight in volume, w/v), xanthan gum 0.25% (w/v), sodium
citrate 0.2% (w/v)] was cooled to 43 1C and inoculated
aseptically with the faecal inoculum (2%, v/v). At the end of
the immobilization procedure, beads with diameters in the
range 1.0–2.0mm were selected by wet-sieving and used for
fermentation. The entire process was completed under
aseptic conditions within 1 h.
Fermentation procedures
The continuous culture fermentation system used in this
study was described by Cinquin et al. (2006). Briefly, this
system consisted of three custom-stirred flat-bottom glass
bioreactors (R1, R2 and R3) arranged in series with working
volumes of 100, 125 and 100mL, respectively, and used to
simulate pH and retention times encountered in the prox-
imal (PCS), transverse (TCS), and distal (DCS) parts of an
infant colon. The first reactor was inoculated with 30% (v/v)
of freshly prepared beads. Retention times were set at 4 h
(R1), 5 h (R2) and 4 h (R3) by adjusting the feed flow rate to
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25mLh1. The pH was maintained at 5.9 and 6.2 in R1 and
R2, respectively, whereas pH in R3 (DCS) was monitored
but not controlled because it stabilized at physiological levels
(6.5–6.6).
For both fermentation experiments, effluent samples
(4mL) were collected daily in the three reactors. Bacteriolo-
gical analyses with plate counts were performed daily.
Metabolite and FISH analyses were performed for the last 3
and 2 days of each fermentation period, respectively. Bead
samples were collected just after the immobilization process,
after 48 h of batch cultures used for bead colonization, and
during the last day of the pseudo-steady-state periods, for
plate counts and microscopy analyses. The pseudo-steady
state was reached when bacterial populations in fermenta-
tion effluents from all reactors did not change by more than
0.5 Log10 units, this corresponding to the last 3 days for
each condition.
Fermentation media
Two independent fermentations were carried out to com-
pare the prebiotic effects of FOS containing 95% of oligo-
fructose with an average degree of polymerization (DP) of
3.6 monomers (Nutrafloras P-95 Canacure, Laval, QC)
Table 1. Bacterial strains used for the fluorescence in situ hybridization probe specificity tests with conditions described in Table 2
Strains Blong209 Bbr PADw pBiBIFz Bif164‰
Bifidobacteria
B. longum bv. infantisz DSMZ 20088 111    111
B. longum bv. suis DSMZ 20211 11    111
B. longum bv. longumz DSMZ 20219 111    111
B. brevez DSMZ 20213  111   111
B. adolescentisz DSMZ 20083   111  111
B. bifidumz DSMZ 20456   111 111 
B. cuniculi DSMZ 20435    111 111
B. pseudolongum ssp. pseudolgum DSMZ 20099     111
B. animalis ssp. animalis DSMZ 20104     11
B. indicum DSMZ 20214     1
B. animalis ssp. lactis DSMZ 10140     111
B. saeculare DSMZ 6531     11
B. subtile DSMZ 20096     111
B. pullorum DSMZ 20433     111
B. dentium DSMZ 20436     111
B. pseudocatenulatumz DSMZ 20438 11    111
B. boum DSMZ 20432     111
B. thermophilumz DSMZ 20210     111
B. angulatumz DSMZ 20098     111
B. merycicum DSMZ 6492     111
B. catenulatumz DSMZ 20224 111    111
Strains Blong209 Bbr PAD pBiBIF EUB 338k
Intestinal bacteria
Collinsella aerofaciens DSMZ 3979     111
Eubacterium eligens DSMZ 3376     11
Eubacterium biforme DSMZ 3989     111
Ruminococcus productus DSMZ 2950     111
Bacteroides fragilis DSMZ 2151     111
Enterococcus faecium DSMZ 20477     111
Streptococcus salivarius DSMZ 20560     111
Lactobacillus fermentum Our collection – – – – 11
Lactobacillus acidophilus DSMZ 20079 – – – – 111
Germond et al. (2002).
wYamamoto et al. (1992).
zMatsuki et al. (2004).
‰Langendijk et al. (1995).
zBifibobacteria species occurring in faecal samples.
kAmann et al. (1995).
111 and 11: strong and medium fluorescent signal, respectively.
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with those of EPS produced by L. rhamnosus RW-9595M.
Fermentation media simulating an infant ileal chyme were
based on the composition described by Cinquin et al. (2004,
2006). The medium composition was calculated from the
composition of a standard infant formula supplemented
with rice starch (Sigma, St Louis, MO) and applying
digestibility indices from the literature. FOS tested at 7.8
and 9.5 g L1 medium corresponds to a diet containing
between ca. 3.5% and 7.5% FOS among carbohydrates, for
a digestibility index of 11% (Molis et al., 1996). The ratio of
the different carbohydrates in the two control media with
maltodextrin (10 and 13 g L1 total carbohydrate for M-10
and M-13, respectively) remained unchanged, with 7%
starch, 18% lactose and 75% maltodextrin in both experi-
ments (Table 3).
During the first fermentation (F1), which lasted for 34
days, the first two substrates tested were FOS (FOS-13) and
maltodextrin (M-13) at 9.8 g L1, i.e. 75% of the total
carbohydrate concentration (13 g L1) (Table 3). During the
third and fourth periods, it was not possible to substitute
EPS for maltodextrin because of high medium viscosity,
which limited EPS addition into the medium to a maximum
level of 1.5 g L1. Therefore, for the EPS test, the total
carbohydrate concentration was decreased to 10 g L1 in
order to reach a significant EPS percentage of 15% (EPS-
10) in the medium carbohydrate fraction. During the third
period (M-10), maltodextrin was reduced to 7.5 g L1 (75%
of the total carbohydrate concentration in the medium with
10 g L1) in order to use this treatment as a control for EPS-
10 (Table 3). The second fermentation (F2), which lasted for
32 days, was performed to assess whether the effects
observed during the fourth period of F1 (EPS-10) were the
result of the addition of EPS or of a lack of assimilable
carbohydrates, since EPS substituted for equivalent amounts
of maltodextrin in the medium. EPS (1.5 g L1) was then
added to medium M-10 containing 10 g L1 carbohydrates
(EPS-11.5). This medium was compared with two other
media containing either 10 (M-10) or 11.5 (M-11.5) g L1
total carbohydrates, with maltodextrin. A medium with a
low FOS concentration (7.5 g L1 substituting for an equiva-
lent amount of maltodextrin) and 10 g L1 total carbohy-
drates was also tested (FOS-10).
Bacterial enumeration
Plate counts were performed within 1 h of sampling. Sam-
ples were serially diluted 10-fold with peptone water (0.1%,
pH 7.0). Four 20 mL drops of each dilution were plated in
duplicate on both selective and nonselective media, as
described previously (Cinquin et al., 2004).
Fluorescence in situ hybridization analyses were per-
formed for the detection of bifidobacteria and total bacterial
populations (Table 2) in fermentation samples from DCS
(last 2 days of the pseudo-steady state of each fermentation
period). Samples were fixed with paraformaldehyde (PFA)
4%, dehydrated with ethanol baths, and applied to glass
slides as described previously (Cinquin et al., 2006). The
slides were hybridized with the various probes (see next
section) and stained with 40,6-diamidino-2-phenylindole
(DAPI). Cells were then counted visually with an Olympus
BX 51 epifluorescence microscope (Olympus America,
Melville, NY) equipped with a monochrome camera, as
already described (Cinquin et al., 2006). Each assay was
done in duplicate.
Probe design and specificity for bifidobacteria
Four bifidobacterial species-specific 16S rRNA-targeted oli-
gonucleotide probes were used in this study (Table 2). The
Bbr probe was previously designed to be used as a forward
PCR primer for Bifidobacterium breve (Germond et al.,
2002). The pBiBIF and PAD probes were used in dot blot
and FISH for the detection of Bifidobacterium bifidum
(Matsuki et al., 2004) and Bifidobacterium adolescentis
(Yamamoto et al., 1992), respectively. An oligonucleotide
probe targetting the small subunit rRNA sequence of
Bifidobacterium longum (including B. suis, B. infantis and
B. longum) (Sakata et al., 2002) was designed with the Arb
software package (Ludwig et al., 2004), the Check-Probe
function of the RDP software package (Maidak et al., 1997),
and the EMBL database. This probe was named (S-S-Blong-
Table 2. Sequences of oligonucleotide probes used for fluorescence in situ hybridization analyses of faecal and fermentation samples and optimal
conditions for hybridization specificity
Sequence (50–30) Targeted Formamide (%)
Temperature ( 1C)
ReferencesTH TW
Eub338 50-GCT GCC TCC CGT AGG AGT-30 Universal eubacterial probe 0 46 48 Amann et al. (1995)
Bif164 50-CAT CCG GCA TTA CCA CCC-3 0 Bifidobacteria 0 46 48 Langendijk et al. (1995)
PAD 50-GCT CCC AGT CAA AAG CG-30 Bifidobacterium adolescentis 15 50 52 Yamamoto et al. (1992)
Bbr 50-GCT CGC ACT GTC GCA TC-30 Bifidobacterium breve 0 50 52 Germond et al. (2002)
Blong209 50-CCC ATC CCA TAC CGC GAA-30 Bifidobacterium longum 0 54 56 This study
pBiBIF 50-CCA CAA TCA CAT GCG ATC ATG-30 Bifidobacterium bifidum 0 50 52 Matsuki et al. (2004)
TH, hybridization temperature; TW, washing temperature.
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0209-b-A-18) according to the nomenclature suggested by
the Oligonucleotide Probe Database (OPD) (Alm et al.,
1996). In this paper, the probe name is abbreviated Blong209.
Hybridization specificity for FISH was optimized for each
probe by testing several temperatures and formamide con-
centrations (up to 35%) in the hybridization buffer to
increase the stringency of the annealing reaction. Bif164
and Eub338 probes were used as positive controls for
bifidobacteria strains and intestinal bacteria, respectively.
Probe validation was performed with 21 bifidobacterial
species as well as with nine other bacterial species commonly
encountered in human faeces (Table 1).
Metabolites analyses
Short-chain fatty acids (SCFA) and isoacids production was
analysed by high-performance liquid chromatography
(HPLC), and ammonia concentration with an ammonia
electrode, as described by Cinquin et al. (2006). Each assay
was done in duplicate. Meanmetabolite concentrations were
calculated for the last 3 days of fermentation; SCFA and
isoacids were expressed in mmol per L (mM), and ammonia
concentration was expressed in mmol per kg of wet-weight
faeces or in mM for fermentation samples.
Quantification of residual EPS in fermentation
effluent samples from DCS
Quantification of residual EPS was performed with fermenta-
tion samples from DCS for the last 2 days of EPS periods
(EPS-10 and EPS-11.5). Samples were heated at 100 1C for
15min, cooled and centrifuged (25min, 13 200 g) to remove
bacteria. An enzymatic treatment was applied to the super-
natant to hydrolyze residual starch and glycoprotein (mucin),
which can interfere with the EPS test. Alpha-amylase (150mL)
(Sigma-Aldrich, St Louis, MO) was added to the supernatant
(2mL) and incubated for 1 h at room temperature. Pronase E
(100mL) (Sigma-Aldrich) was then added and incubated for
20h at 37 1C. After the enzymatic treatment, samples were
ultrafiltrated and diafiltrated to eliminate residual low-mole-
cular-weight sugars in the filtrate and recover nonmetabo-
lized EPS using the method developed by Bergmaier et al.
(2001). EPS in sample concentrates was quantified using the
phenol-sulphuric test (Dubois et al., 1956). Ultrafiltrations
were performed in duplicate for each sample.
Statistical analyses
A one-way analysis of variance (ANOVA) was performed using
JMPINs (SAS Institute Inc., Cary, NC) to test the effects of
FOS and EPS on bacterial populations and metabolite
production during the last 3 days of the fermentation
periods. When significant differences were found below a
probability level of 0.05, treatment means were compared
using the Tukey–Kramer-HSD test.
RESULTS
Probe design and evaluation of probe specificity
Four species-specific probes were used for FISH analyses of
faecal and fermentation samples (Table 2). Blong209 was
designed in this study to detect Bifidobacterium longum
(including the former Bifidobacterium infantis, Bifidobacter-
ium suis and B. longum) (Sakata et al., 2002). The target
region used to design the oligonucleotide probe specific for
B. longum was fully complementary to 16S rRNA of B.
infantis, B. longum and B. suis, but also to Bifidobacterium
indicum and Bifidobacterium pseudolongum (Fig. 1). The
specificity of the four probes used in this study was tested
against 21 bifidobacterial species and nine other bacterial
species commonly encountered in human faeces (Table 1).
For each probe a good fluorescent signal was obtained.
Under our FISH conditions (Table 2), the PAD and Bbr
probes specifically hybridized with Bifidobacterium adoles-
centis and Bifidobacterium breve, respectively. pBiBIF
hybridized with both Bifidobacterium bifidum and Bifidobac-
terium cuniculi, and Blong209 hybridized with its target
species B. longum, but also with Bifidobacterium pseudocate-
nulatum and Bifidobacterium catenulatum, with only three
mismatchs at the 50 end of the 16S rRNA target region
Fig. 1. Sequence of the Blong209 probe shown
on the top of a 16S rRNA gene alignment
(region 209–226 according to Eshcerichia coli
consensus numbering) for Bifidobacterium
longum and related species (bv : biovar). Dashes
indicate full complementarity with the target
sequence. There are at least three mismatches
with sequences of nontarget microorganisms.
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(Fig. 1). Surprisingly, Blong209 did not hybridize with B.
pseudolongum, nor with B. indicum.
Effect of FOS and EPS on immobilized cell
populations
All bacterial populations detected in faecal samples were also
present in beads for both fermentations. At the end of the
first stabilization period (M-13 and M-10 for F1 and F2,
respectively), the differences in bacterial counts of beads
between F1 and F2, and between beads and their respective
inocula were generally below 0.7 Log10CFUg1. The excep-
tions were for staphylococci, lactobacilli, Gram-positive
cocci and clostridia in F1, and for bifidobacteria and
clostridia in F2, which showed greater differences between
faecal inoculum and beads, and, for staphylococci, lactoba-
cilli and clostridia, between the two faecal inocula.
During F1, the replacement of 9.5 g L1 of maltodextrin
(M-13) in the medium by FOS (FOS-13) induced an
increase in bifidobacteria (from 9 to 9.8 Log10CFUmL1)
and lactobacilli (from 5.3 to 6.3 Log10CFUmL1), and a
decrease in coliforms (from 9.6 to 7.3 Log10CFUmL1).
The reduction in total carbohydrate concentration of the
medium from 13 (for M-13 and FOS-13) to 10 g L1 (M-10)
induced a general decrease (minus 0.4 to 2.5 Log10) for
most populations in beads, except for coliforms and
clostridia, which increased by 1.2 and 0.8 Log10CFUmL1,
respectively, compared with FOS-13. The replacement of
1.5 g L1 maltodextrin (M-10) by EPS (EPS-10) led to a
decrease in clostridia counts (from 7.3 to 6.1 Log10
CFUmL1), and an increase for staphylococci (from 6.9 to
8.6 Log10CFUmL1).
For F2, only limited changes in bacterial counts occurred
during supplementation of M-10 with 1.5 g L1 of EPS (EPS-
11.5). Compared with M-10, FOS-10 resulted in decreases of
staphylococci (from 7.7 to 5.9 Log10CFUmL1) and coli-
forms (from 9.7 to 7.3 Log10CFUmL1). The increase in total
carbohydrates from 10 (M-10) to 11.5 (M-11.5) g L1 induced
a decrease in bacteroides (from 9.2 to 8.3 Log10CFUmL1),
staphylococci (from 7.7 to 5.9 Log10CFUmL1), coliforms
(from 9.7 to 6.4 Log10CFUmL1) and clostridia (from 8.5 to
7.5 Log10CFUmL1) counts.
Effects of FOS and EPS on free cell populations
Counts for the main bacterial populations in the effluents
from the three reactors and two fermentations were affected
by the carbohydrate composition of the medium (Table 4).
The replacement of maltodextrin (M-13) by FOS (FOS-13)
in F1 induced an increase in bifidobacteria and lactobacilli
numbers in R3 (DCS), whereas bacteroides, coliforms, and
clostridia decreased (Po 0.05). This effect was also signifi-
cant in R1 and R2 for lactobacilli and in R2 for coliforms.
When the systemwas fed with M-10 during the third period,
bacterial populations in the effluent from R3 were very close
to those for M-13, except for coliforms, which were lower.
Compared with M-10, replacement of 1.5 g L1 maltodex-
trin by EPS (EPS-10) induced a significant increase in
facultative anaerobes (Po 0.0005) in all reactors, mainly
owing to an increase in staphylococci counts, and in Gram-
positive cocci to a lesser extent. A significant decrease of
lactobacilli was also observed in R1 and R3 for EPS-10
compared with M-10.
During the second fermentation experiment (F2), the
addition of 1.5 g L1 of EPS (EPS-11.5) to medium M-10
with maltodextrin induced a significant decrease in staphy-
lococci, Gram-positive cocci and lactobacilli, with major
effects observed in R3 (DCS), accompanied by a decrease in
total anaerobic populations. On the other hand, EPS-11.5
induced significantly higher numbers for Gram-positive
cocci (R1 and R3) and staphylococci (all three reactors),
and lower counts for lactobacilli (all reactors) compared
with M-11.5. The replacement of 7.5 g L1 maltodextrin
(M-10) by FOS (FOS-10) did not result in increases of
bifidobacteria nor of lactobacilli populations, but lower
numbers of Gram-positive cocci and staphylococci were
observed in all three reactors. However, the switch from
FOS-10 to M-11.5 did not change bacterial populations in
the effluents, except for staphylococci, which decreased
significantly in R1 and R3, and lactobacilli, which slightly
increased in all three reactors.
Effect of FOS and EPS on bifidobacterial species
in effluent fermentation
Probes Eub338 and Bif164 were used to measure total
anaerobic populations and bifidobacteria. Four species-
specific probes for B. longum, B. breve, B. adolescentis and
Table 3. Carbohydrate composition of fermentation media tested
during two continuous colonic fermentation experiments
Fermentation 1 M-13 FOS-13 M-10 EPS-10
Time period (days) 2–14 15–22 23–29 30–34
Total carbohydrates (g L1) 13 13 10 10
Maltodextrin (g L1) 9.8 – 7.5 6
FOS (g L1) – 9.8 – –
EPS (g L1) – – – 1.5
Lactose (g L1) 2.3 2.3 1.8 1.8
Rice starch (g L1) 0.9 0.9 0.7 0.7
Fermentation 2 M-10 EPS-11.5 FOS-10 M-11.5
Time period (days) 2–11 12–18 19–25 26–33
Total carbohydrates (g L1) 10 11.5 10 11.5
Maltodextrin (g L1) 7.5 7.5 – 9
FOS (g L1) – – 7.5 –
EPS (g L1) – 1.5 – –
Lactose (g L1) 1.8 1.8 1.8 1.8
Rice starch (g L1) 0.7 0.7 0.7 0.7
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B. bifidum were used to monitor bifidobacteria counts in
faeces and fermentation samples from R3 for the two fer-
mentation experiments (Table 2). Faeces from baby 2 used in
F2 were highly colonized by bifidobacteria, which represented
90% of the anaerobic populations measured with Eub338
(Table 5). The total bifidobacterial population from baby 2
was dominated by B. breve (10.5 Log10CFUmL1), followed
by B. longum (10.1 Log10CFUmL1); B. adolescentis and
B. bifidum were not detected. All four bifidobacterial species
were detected in F2, whereas B. adolescentis and B. bifidum
were not detected in F1 (Table 5). In both fermentations, B.
longum was the dominant species, accounting for 43–76% of
the total bifidobacterial population measured with Bif164.
During F1, FOS-13 treatment did not change the total
bifidobacterial population tested with Bif164 compared
with M-13, which was not different from M-10. However,
bifidobacteria counts were lower during EPS-10 compared
with M-10, although this difference was not statistically
significant. No statistical difference was detected for B.
longum and B. breve among tested treatments.
In F2, total bifidobacteria numbers did not change with
medium composition, as for B. breve, B. adolescentis, and B.
bifidum counts. However, FOS-10 led to a significant
increase in B. longum counts compared with M-10 and
EPS-11.5. No significant effect was observed when FOS-10
was compared with M-11.5, which was not significantly
different from M-10 and EPS-11.5. The proportion of B.
longum in the total bifidobacteria populations (76%) was
higher than in the other treatments (43–67%).
Effects of FOS and EPS on metabolic activities
Total SCFA concentrations ranged from 97.1 to 197.4mM
and generally increased from R1 to R3 for both F1 and F2
Table 4. The effect of medium carbohydrate composition on bacterial populations measured by plate counts in effluents from the three reactors for
two fermentation experiments
Fermentation 1ab Fermentation 2ab
M-13 FOS-13 M-10 EPS-10 M-10 EPS-11.5 FOS-10 M-11.5
PCS (R1)
Facultative anaerobes 7.9a 7.9a 8.0a 8.7b 8.2a 7.9a 8.0a 8.0a
Total anaerobes 10.0a 10.1a 9.8a 10.0a 9.9a 10.1a 10.1a 10.0a
Bifidobacteria 9.6a 9.9a 9.4ab 8.9b 9.7a 9.8a 9.5a 9.7a
Bacteroides 7.9a 7.6a 7.9a 8.0a 7.9a 8.0a 7.6b 7.8ab
Gram 1 cocci 7.9a 7.4a 7.7a 8.4b 8.0a 7.7a 7.3b 7.0b
Staphylococci 7.5ab 7.2a 7.8b 8.3c 6.7a 5.7b 6.1b 4.3c
Coliforms 7.8a 7.6ab 6.8b 7.3ab 7.6a 7.8a 7.6a 8.0a
Lactobacilli 5.2a 6.4b 5.6c 4.9d 6.3ab 5.9c 6.1bc 6.5a
Clostridia 7.5a 7.2a 7.7a 7.1a 6.6a 6.6a 6.5a 6.5a
TCS (R2)
Facultative anaerobes 8.2a 8.2a 8.5b 8.7c 8.3a 8.0a 8.1a 8.0a
Total anaerobes 10.3a 10.1a 10.1a 10.1a 10.0a 10.0a 10.0a 10.1a
Bifidobacteria 9.6a 9.9a 9.8a 9.8a 9.4a 9.5a 9.6a 9.7a
Bacteroides 8.3ab 8.0a 8.8b 8.7b 8.8a 8.7a 8.2b 8.2b
Gram 1 cocci 8.1a 8.1a 8.3ab 8.4b 7.9a 7.7a 7.3b 7.1b
Staphylococci 7.9a 7.9a 7.9a 8.4b 6.4a 5.7b 5.4bc 4.8c
Coliforms 8.1a 7.5b 7.3b 7.4b 8.0a 8.0a 8.1a 7.9a
Lactobacilli 5.7a 6.5b 5.9a 5.8a 6.5ac 5.8b 6.1a 6.5c
Clostridia 7.5a 7.5a 7.5a 7.5a 6.8a 6.6a 6.5a 6.8a
DCS (R3)
Facultative anaerobes 7.9a 7.7a 8.0a 8.7b 8.2a 8.1a 8.2a 8.0a
Total anaerobes 9.9a 9.9a 9.8a 9.9a 10.0a 9.6b 9.9a 9.9a
Bifidobacteria 9.2a 9.8b 9.3a 8.8c 9.4a 9.1a 9.1a 9.2a
Bacteroides 7.8a 7.5b 8.1ac 8.3c 8.8a 8.6ab 8.4b 8.5b
Gram 1 cocci 7.9ab 7.1b 7.8ab 8.3b 8.0a 7.4b 7.1b 7.1b
Staphylococci 6.0a 5.8a 6.7ab 7.5b 6.5a 5.6b 5.4b 4.5c
Coliforms 7.9a 7.2b 7.0b 7.1b 8.1a 8.0a 7.9a 7.9a
Lactobacilli 5.4ac 6.3b 5.8a 4.9c 6.6a 5.8b 6.1b c 6.4c
Clostridia 7.4a 6.8b 7.6a 7.3a 6.8a 6.4b 6.0c 5.7c
PCS, proximal colon simulation; TCS, transverse colon simulation; DCS, distal colon simulation.
aMean values for the three last days of pseudo-steady-state periods, expressed in Log10 (CFU per mL).
bEffect of carbohydrate substrates on bacterial populations: values with different letters in a row are significantly different with the Tukey–Kramer HSD
test (Po 0.05).
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(Table 6). During F1, the total SCFA concentration in all
three reactors increased in the order: EPS-10, M-10, M-13,
FOS-13. The decrease in total SCFA in EPS-10 was essen-
tially the result of a decrease in acetic acid production. The
high SCFA production for FOS-13 in R1 was associated with
high acetic and propionic acid concentrations. FOS-13, M-
10 and EPS-10 induced a significant decrease in isoacids in
R3 (DCS) compared with M-13.
During F2, the total SCFA concentration increased in all
three reactors in the order: M-10, EPS-11.5, FOS-10, M-
11.5. In R1, FOS-10 and M-11.5 showed significantly higher
concentrations of propionic and butyric acids compared
with M-10. The highest concentration of butyric acid was
measured in R1 during FOS-10. In R2, compared with
M-10, the increase in total SCFA was mainly the result of
an increase of acetic acid production for EPS-11.5, and of
both acetic and propionic acids for FOS-10 and M-11.5. In
R3, the total SCFA production for FOS-10 and M-11.5 was
significantly higher than for M-10 and EPS-11.5, mainly as a
result of increased acetic acid production. During F2, no
significant changes of isoacid concentration were observed
for all conditions and reactors.
In both fermentations, ammonia concentration increased
from R1 to R3 for all tested periods (Table 7). Compared
with M-13, FOS-13 significantly decreased ammonia pro-
duction in R2 and R3 during F1, whereas no differences were
observed between EPS-11.5 and M-11.5.
In F2, significant differences in ammonia production
were only detected in R1 (PCS) (Table 7). The lowest
concentrations of ammonia were measured for FOS-10 and
M-11.5. EPS-11.5 also showed a significantly lower concen-
tration of ammonia compared with M-10.
Analysis of EPS in EPS powder and fermentation
samples
The content in low-molecular-weight sugars of the EPS
powder was estimated from the carbohydrate concentration
measured by phenol-sulphuric assay in the filtrate at the end
of the purification procedure, and was 1.4 0.2% and
1.1 0.1% for the two powder preparations used for F1
and F2. The protein content for the two powders was
5.2 1.1%, as measured by the Lowry test. The EPS
concentration in the fresh media used for EPS-10 and EPS-
11.5 was 1481 107 and 1496 119mg L1, respectively.
Residual EPS concentrations in the effluent from R3 (DCS)
were 1476 10 and 1469 15mg L1, respectively, for EPS-
Table 5. The effect of medium carbohydrate composition on bifidobacteria populations determined with fluorescence in situ hybridization (FISH)
analyses in effluent samples from distal colon simulation (R3) during two colonic fermentations F1 and F2
Fermentation F1ab
M-13 FOS-13 M-10 EPS-10 Faeces
FISH counts % FISH counts % FISH counts % FISH counts % FISH counts %
Eub338 10.6 10.5 10.5 10.2
Bif164 10.4a 71c 10.4a 84b 10.3ab 76b 10.1b 80b Nd
Blong209 10.3a 74 10.3a 66 10.1a 57 9.9a 61 Nd
Bbr 9.8a 25 9.8a 23 9.4a 12 9.3a 13 Nd
PAD ND ND ND ND Nd
pBiBIF ND ND ND ND Nd
Fermentation F2ab
M-10 EPS-11.5 FOS-10 M-11.5 Faeces
FISH counts % FISH counts % FISH counts % FISH counts % FISH counts %
Eub338 10.5 10.6 10.6 10.5 10.9
Bif164 10.4a 72b 10.4a 65b 10.5a 76b 10.4a 80c 10.8 90c
Blong209 10.0a 43 10.1a 49 10.4b 76 10.2ab 67 10.1 20
Bbr 9.8a 29 9.9a 31 9.7a 17 9.6a 17 10.5 50
PAD 9.9a 33 9.8a 28 9.8a 19 9.7a 22 ND
pBiBIF 9.1a 5 9.0a 4 9.0a 3 9.0a 4 ND
aMean values of the two last days of each pseudo-steady state expressed in Log10 (cell number per mL).
bEffect of carbohydrate substrates on bifidobacteria populations: values with different letters in a row are significantly different with the Tukey–Kramer
HSD test (P o 0.05).
cPercentage representing the proportion of bifidobacteria compared with the total bacterial population measured by FISH with the probe Eub338.
ND, not detected, value below the detection limit of the method [6 Log10 (cell number per mL)].
Nd, not determined.
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10 in F1 and EPS-11.5 in F2, which shows that EPS was not
metabolized during intestinal fermentation.
Discussion
A number of chemostat systems have been designed to
model the ecosystem of the human colon and to study
bacterial composition and metabolism under controlled
conditions. To solve the limitations of free-cell colonic
models, we developed a new in vitro infant colonic model
composed of a single-stage culture with immobilized infant
faeces (Cinquin et al., 2004), which was further developed
into a three-stage chemostat model composed of three
reactors in series simultaneously simulating the proximal,
Table 6. Effect of medium carbohydrate composition on short-chain fatty acid and isoacid concentrations in effluents from the three reactors for two
colonic fermentations, F1 and F2
Fermentation 1ab (mM)
M-13 FOS-13 M-10 EPS-10
PCS (R1)
Total SCFA 140.9a 166.5a 108.8b 97.1b
Acetate 96.0ab 108.3b 77.7a 53.4c
Propionate 25.6a 35.5b 16.4c 24.1a
Butyrate 19.3a 22.7a 14.7a 19.6a
Isoacids 10.1a 12.1a 10.3a 10.5a
TCS (R2)
Total SCFA 161.1a 197.4b 136.3a 104.1c
Acetate 102.5a 118.4a 84.3b 50.9c
Propionate 33.1a 45.7b 26.0c 28.4ac
Butyrate 25.5a 33.3a 26.0a 24.8a
Isoacids 17.9a 20.7a 17.5a 10.4a
DCS (R3)
Total SCFA 184.8a 192.8a 146.1b 130.1c
Acetate 114.9a 119.7a 94.0b 65.6c
Propionate 41.3a 42.1a 25.2b 34.2ab
Butyrate 28.6a 31.0a 26.9a 30.3a
Isoacids 22.0a 13.1b 15.9b 16.4b
Fermentation 2ab (mM)
M-10 EPS-11.5 FOS-10 M-11.5
PCS (R1)
Total SCFA 118.6a 125.2ab 137.4b 138.9b
Acetate 92.7a 97.9a 102.4a 108.6a
Propionate 20.4a 19.8a 26.9b 22.6ab
Butyrate 5.5a 7.5b 8.2c 7.7bc
Isoacids 3.6a 3.6a 3.6a 4.0a
TCS (R2)
Total SCFA 141.4a 150.4b 159.1b 171.5c
Acetate 104.4a 111.4ab 113.3b 126.3c
Propionate 25.5a 26.7a 32.1b 31.8b
Butyrate 11.5a 12.4a 13.6a 13.4a
Isoacids 10.2a 10.6a 10.2a 13.4a
DCS (R3)
Total SCFA 157.3a 158.3ab 167.9b 178.2c
Acetate 115.3a 115.3a 119.9b 131.4c
Propionate 29.0a 29.5a 33.1a 32.5a
Butyrate 13.0a 13.8a 13.9a 14.3a
Isoacids 12.6a 9.9a 10.6a 10.1a
PCS, proximal colon simulation; TCS, transverse colon simulation; DCS, distal colon simulation.
aMean values of the three last days of each pseudo-steady state.
bEffect of carbohydrate substrates on organic acid production: values with different letters in a row are significantly different with the Tukey–Kramer
HSD test (Po 0.05).
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transverse and distal parts of the infant colon (Cinquin et al.,
2006). This immobilized-cell model was validated by micro-
biological analyses using both plate counts on selective
media and molecular methods, as well as metabolic data
(Cinquin et al., 2004, 2006). Indeed, we showed that cell
immobilization induced a high cell density in beads and
fermentation medium, comparable with in vivo values,
improved stability, and preserved bacterial diversity of the
faecal inoculum over long culture periods. The maintenance
of a stable community in all reactors can be explained by
immobilized faecal microbiota growth, cell release from
beads, and eventually growth of free cells in the bulk
medium. In the present study, we used this new three-stage
chemostat model with immobilized cells to investigate the
prebiotic effects of EPS produced by L. rhamnosus RW-
9595M on infant faecal microbiota, in parallel with a well-
characterized prebiotic, fructo-oligosaccharides (FOS), with
two continuous culture experiments. In a previous paper
(Cinquin et al., 2006), we reported a detailed analysis of
stabilization periods for F1 (M-13) and F2 (M-10).
In this study, replacement of maltodextrin in M-13 by
FOS during F1 (FOS-13) gave increased numbers of lacto-
bacilli, and of bifidobacteria to a lesser extent, while less
desirable bacteria such as coliforms, clostridia and bacter-
oides showed decreased numbers in beads and fermentation
effluents (Table 4). Similar effects have been reported for
FOS for various in vitro (Michel et al., 1998; Rycroft et al.,
2001a) and in vivo (Gibson et al., 1995) studies in adults or
following the ingestion of a prebiotic mixture of FOS and
galacto-oligosaccharides in infants (Fanaro et al., 2005). In
our study, a larger increase in numbers was observed for
lactobacilli (plus 0.8 to 1.2 Log10 for FOS-13 compared with
M-13, Po 0.05), whereas only a slight increase in bifido-
bacteria was observed (plus 0.3 to 0.6 Log10, Po 0.05 only
in R3) in the fermentation effluents from the three reactors
for F1. This low effect of FOS on the number of bifidobac-
teria is probably a result of the high initial bifidobacteria
counts measured in the M-13 control (9.6 Log10CFU
mL1). Kleessen et al. (2001) did not observe any bifidogenic
effects of inulin on microbiota in vivo in rats associated with
human faecal microbiota, probably because of the high
bifidobacteria counts in the control. Indeed, Rycroft et al.
(2001b) showed a clear correlation between the increase in
bifidobacterial populations and their initial number, with a
stronger effect for low initial levels of bifidobacteria. In
contrast to F1, no stimulation of lactobacilli nor of bifido-
bacteria was observed during the substitution of maltodex-
trin in F2 (M-10) for FOS (FOS-10). This lack of
stimulation, compared with F1, might be explained by the
lower FOS concentration tested in F2 (7.5 vs. 9.8 g L1)
combined with high initial counts of lactobacilli and bifido-
bacteria before FOS treatment (6.3 and 9.7 Log10CFUmL1
respectively). Moreover, the FOS effect is known to be dose-
dependent, as observed in infants (Moro et al., 2002) and
adults (Bouhnik et al., 1999).
Fluorescence in situ hybridization analysis confirmed the
high numbers of bifidobacteria in both fermentations
(10.1–10.5 Log10 cell numbermL1). Close to 100% of the
bifidobacterial community was recovered with the four
species-specific probes tested (Table 5), while B. longum
was the major population, representing 57–74% of the
bifidobacterial community. Only B. longum and B. breve
were detected in F1, whereas the four species were detected
in F2, including B. adolescentis and B. bifidum, which were
below the detection limit in the faecal inoculum. FOS did
not lead to significant increases in total counts of bifidobac-
teria in either fermentation. In F2, however, FOS (FOS-10)
changed the balance for bifidobacterial species, and specifi-
cally increased the numbers and proportion of B. longum
compared with M-10 and EPS-11.5. This result is in agree-
ment with data from Bielecka et al. (2002), who showed that
B. longum, B. infantis and B. animalis were able to ferment
FOS better than other bifidobacterial species. This effect was
not observed in F1, probably because of the initially
high proportion of B. longum present in the fermentation
effluents before FOS treatment. In the present study, the
high levels of bifidobacteria in both faecal samples and
fermentation effluents were probably responsible for the
lack of bifidogenic effect observed with FOS. However,
despite the limited effect of FOS on total numbers of
Table 7. Effect of medium carbohydrate composition on ammonia production in the three reactors for two colonic fermentation experiments, F1
and F2
Fermentation F1ab (mM) Fermentation F2ab (mM)
M-13 FOS-13 M-10 EPS-10 P M-10 EPS-11.5 FOS-10 M-11.5 P
PCS (R1) 7.7ab 4.8a 10.23bc 12.9c o 0.005 9.1a 6.9b 1.7c 1.6c o 0.0005
TCS (R2) 24.6a 14.4a 24.5a 23.3a o 0.0005 29.4a 28.5a 29.7a 29.2a
DCS (R3) 26.3a 16.5b 29.1c 35.4d o 0.0005 33.5a 31.7a 32.3a 32.2a
PCS, proximal colon simulation; TCS, transverse colon simulation; DCS, distal colon simulation.
aMean values of the three last days of each pseudo-steady state.
bEffect of carbohydrate substrates on ammonia production: values with different letters in a row are significantly different with the Tukey–Kramer
HSD test.
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bifidobacteria, the observed stimulation of lactobacilli and
B. longum together with the decrease in coliforms are in
agreement with published data (Gibson et al., 1995; Bielecka
et al., 2002).
Moreover, FOS was well fermented by the bacterial
community established in the continuous culture, and gave
increases in SCFA production and decreases in ammonia.
This supports other data in the literature (Gibson &
Roberfroid, 1995) and confirms the good reactivity and
validity of our system for modelling intestinal fermenta-
tions. However, the reduction in ammonia production was
observed in all three reactors in F1, but was only observed in
R1 for F2. This difference is probably related to the lower
amounts of FOS tested in F2 (FOS-10 with 7.5 g L1 of FOS)
compared with F1 (FOS-13 with 9.8 g L1 of FOS). Because
FOS are easily metabolized by the microbiota, they might
have been completely fermented in the first reactor during
F2. In contrast with in vitro data obtained with adult faecal
microbiota, which showed the butyrogenic effects of FOS on
SCFA production (Rycroft et al., 2001a), the increase in
SCFA production in our study was obtained without
modifying the butyrate ratio. This absence of butyrogenic
effect during FOS fermentations has been observed in vitro
with infant microbiota (Flickinger et al., 2002), and may be
associated with the reduced bacterial complexity of infant
microbiota and with lower concentrations or the absence of
butyrate producers compared with adult microbiota
(Harmsen et al., 2000; Cinquin et al., 2006). It has been
shown that the growth or activity of these bacteria can be
stimulated by prebiotics and complex carbohydrates (Pryde
et al., 2002), and that infants have a lower capacity to
produce butyrate than adults (Parrett et al., 1997).
The central aim of this study was to investigate the
potential prebiotic effects of EPS produced by L. rhamnosus
RW-9595M on infant bacterial microbiota compared to
FOS, a well-known prebiotic. In F1, the substitution of
1.5 g L1 of maltodextrin (M-10) by the same amount of
EPS (EPS-10) induced a decrease in total SCFA concentra-
tions, believed to be associated with a decrease in acetate
ratios, and increases in propionate and butyrate ratios.
Similar effects were reported for long compared with short
retention times during in vitro colonic fermentations by
Macfarlane et al. (1998). This suggests that a lower fermen-
table carbohydrate concentration was available for EPS-10
compared with M-10. This was confirmed by an increase in
ammonia concentrations in EPS-10 compared with M-10.
Indeed, ammonia, which is produced during protein break-
down, reflected the increase in the protein/carbohydrate
ratio between M-10 and EPS-10. These results were con-
firmed during F2 by the lack of stimulation of SCFA
production observed in EPS-11.5 (M-10 plus 1.5 g L1 EPS)
compared with M-10, whereas M-11.5 (M-10 plus 1.5 g L1
maltodextrin) resulted in SCFA increases. Data from both
fermentation experiments suggest that EPS was not meta-
bolized by the infant microbiota. Moreover, quantification
of residual EPS in the fermented media confirmed that the
EPS used in this study was not fermented.
In F1, increases in the facultative anaerobic populations
observed for EPS-10 compared with M-10 could be a result
of reductions of fermentable carbohydrates in the medium
or of specific effects of EPS. A second fermentation, F2, was
carried out to differentiate between these effects. The addi-
tion of EPS in medium M-10 (EPS-11.5) led to decreases in
lactobacilli and staphylococci counts compared with M-10
in all three reactors, although the amount of fermentable
carbohydrates remained the same.
Data obtained with FOS in this study are in agreement
with previous published studies, supporting the validity of
the in vitro model using immobilized faecal bacteria. More-
over, we showed that the balance of different bifidobacterial
species could be modified by FOS, with a specific stimulation
of B. longum, although no effect was detected on the total
bifidobacterial population. To our knowledge, this is the first
time that the effects of different polysaccharide substrates on
bifidobacterial species have been studied by FISH in a
complex bacterial ecosystem. EPS produced by L. rhamnosus
RW-9595M was not metabolized by infant microbiota and
did not exert any prebiotic effects. On the contrary, our data
suggest that this EPS has a detrimental effect on bacterial
balance by decreasing lactobacilli numbers.
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